NO308587B1 - FremgangsmÕte for fremstilling av en konsentrert fibrinogen- oppløsning og anvendelse derav - Google Patents

FremgangsmÕte for fremstilling av en konsentrert fibrinogen- oppløsning og anvendelse derav

Info

Publication number
NO308587B1
NO308587B1 NO930294A NO930294A NO308587B1 NO 308587 B1 NO308587 B1 NO 308587B1 NO 930294 A NO930294 A NO 930294A NO 930294 A NO930294 A NO 930294A NO 308587 B1 NO308587 B1 NO 308587B1
Authority
NO
Norway
Prior art keywords
preparation
soln
fibrinogen solution
concentrated fibrinogen
fibrinogen
Prior art date
Application number
NO930294A
Other languages
English (en)
Norwegian (no)
Other versions
NO930294L (no
NO930294D0 (no
Inventor
Johann Hock
Hermann Karges
Original Assignee
Aventis Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Behring Gmbh filed Critical Aventis Behring Gmbh
Publication of NO930294D0 publication Critical patent/NO930294D0/no
Publication of NO930294L publication Critical patent/NO930294L/no
Publication of NO308587B1 publication Critical patent/NO308587B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
NO930294A 1992-01-29 1993-01-28 FremgangsmÕte for fremstilling av en konsentrert fibrinogen- oppløsning og anvendelse derav NO308587B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4202667A DE4202667C1 (https=) 1992-01-29 1992-01-29

Publications (3)

Publication Number Publication Date
NO930294D0 NO930294D0 (no) 1993-01-28
NO930294L NO930294L (no) 1993-07-30
NO308587B1 true NO308587B1 (no) 2000-10-02

Family

ID=6450618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930294A NO308587B1 (no) 1992-01-29 1993-01-28 FremgangsmÕte for fremstilling av en konsentrert fibrinogen- oppløsning og anvendelse derav

Country Status (10)

Country Link
US (1) US6277961B1 (https=)
EP (2) EP1362595A1 (https=)
JP (1) JP3367698B2 (https=)
KR (1) KR100276372B1 (https=)
AT (1) ATE279202T1 (https=)
AU (1) AU666905B2 (https=)
CA (1) CA2088343C (https=)
DE (2) DE4202667C1 (https=)
ES (1) ES2231766T3 (https=)
NO (1) NO308587B1 (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
DE19851334C2 (de) * 1998-11-06 2000-09-28 Aventis Behring Gmbh Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung
US6447774B1 (en) 1998-11-18 2002-09-10 Aventis Behring Gmbh Stabilized protein preparations for a tissue adhesive
US7276235B2 (en) 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
WO2001048016A1 (en) * 1999-12-23 2001-07-05 Csl Limited Separation of fibrinogen from plasma proteases
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
DE10103706A1 (de) * 2001-01-26 2002-08-14 Aventis Behring Gmbh Verwendung eines Hydrogenperoxid-Plasma-Sterilisationsverfahrens für die schonende Sterilisation temperaturempfindlicher Produkte
WO2003028743A1 (en) * 2001-10-03 2003-04-10 Woolverton Christopher J Storage-stable fibrinogen solutions
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
DE10392686T5 (de) 2002-05-24 2005-07-07 Biomet Mfg. Corp., Warsaw Vorrichtung und Verfahren zum Trennen und Konzentrieren von Flüssigkeiten, welche mehrere Komponenten enthalten
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
DE10261126A1 (de) * 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
WO2006086201A2 (en) 2005-02-07 2006-08-17 Hanuman Llc Platelet rich plasma concentrate apparatus and method
WO2006086199A1 (en) 2005-02-07 2006-08-17 Hanuman Llc Platelet rich plasma concentrate apparatus and method
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
WO2008127639A1 (en) 2007-04-12 2008-10-23 Biomet Biologics, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
HUE028626T2 (en) * 2008-06-23 2016-12-28 Bio-Products & Bio-Engineering Ag Stable, functionally intact, virus-inactivated fibrinogen during storage
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
EP2556842A1 (en) 2011-08-11 2013-02-13 Bioftalmik, S.L. Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
KR101841587B1 (ko) * 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR416983A (fr) * 1910-05-21 1910-11-03 Henry Tawsitt Pelle à feu combinée avec un rateau
CH586233A5 (https=) * 1971-01-18 1977-03-31 Pentapharm Ag
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
DE3203775A1 (de) 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
CH673117A5 (https=) * 1986-12-10 1990-02-15 Ajinomoto Kk
FR2618784B1 (fr) * 1987-07-30 1990-04-06 Lille Transfusion Sanguine Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
IT1223824B (it) * 1988-09-15 1990-09-29 Siem Srl Dispositivo per la regolazione del l'orientamento dei fari di un autoveicolo
FR2650508A1 (fr) * 1989-08-01 1991-02-08 Fondation Nale Transfusion San Colle pasteurisee pour reunir des tissus humain ou animal
FR2663226B1 (fr) * 1990-06-15 1994-11-18 Fondation Nale Transfusion San Colle biologique fluide.
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive

Also Published As

Publication number Publication date
EP0554570A3 (en) 1993-09-29
CA2088343C (en) 2005-01-11
DE4202667C1 (https=) 1993-05-13
EP0554570A2 (de) 1993-08-11
NO930294L (no) 1993-07-30
ATE279202T1 (de) 2004-10-15
DE59210000D1 (de) 2004-11-18
NO930294D0 (no) 1993-01-28
CA2088343A1 (en) 1993-07-30
US6277961B1 (en) 2001-08-21
KR930016109A (ko) 1993-08-26
EP0554570B1 (de) 2004-10-13
ES2231766T3 (es) 2005-05-16
JPH05286999A (ja) 1993-11-02
JP3367698B2 (ja) 2003-01-14
AU666905B2 (en) 1996-02-29
EP1362595A1 (de) 2003-11-19
KR100276372B1 (ko) 2001-11-22
AU3206493A (en) 1993-08-05

Similar Documents

Publication Publication Date Title
NO308587B1 (no) FremgangsmÕte for fremstilling av en konsentrert fibrinogen- oppløsning og anvendelse derav
ATE330606T1 (de) Verfahren zur vorbeugung von nmda-rezeptor vermittelten neuronalen schäden
AU648414B2 (en) A blood product, a method of producing the same and a method of determining the virus inactivation capacity of an inactivation treatment
DE59209922D1 (de) Thrombin sowie Verfahren zu seiner Herstellung
AU2161888A (en) Anti-acne composition
NO178284C (no) Fremgangsmåte ved fremstilling av en blanding som induserer en binding
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
ES2141214T3 (es) Preparacion de factor xiii de coagulacion de la sangre desprovisto de virus.
ATE70715T1 (de) Bindungsinduzierende komposition.
ATE166881T1 (de) Verfahren zur herstellung von faktor viii
DK0573605T3 (da) Fremstilling af faktor IX
ATE162218T1 (de) Verfahren zur herstellung eines virussicheren thrombinkonzentrates
ATE100455T1 (de) Verfahren zur herstellung von l-alphaglyzerylphosphoryl-d-myoinositol und dessen salzen.
WO1990003172A3 (en) Bile acids for treatment of viral infections
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
DE3768043D1 (de) Stabile, waessrige vincristinsulfatloesung.
DE69009668D1 (de) Verfahren zur herstellung von aktiviertem protein c.
NO980371L (no) Framgangsmåte for framstilling av en lösning av N-metylmorfolin-N-oksid i vann
SE8703512D0 (sv) Medel for tandbehandling
GR77250B (https=)
DE58901557D1 (de) Verfahren zur herstellung von 1,2-disulfon-verbindungen.
GB2216422B (en) Method for sterilising aqueous saline solution.
ATA261387A (de) Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
HUT48666A (en) Process for stabilizing iron compounds during well treating operations
ATA250986A (de) Verfahren zur herstellung neuer, optisch aktiver tert.butylester der weinsaeure und einiger o,o-diacylderivate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees